Amnion-derived mesenchymal stromal cells (AMSCs) may benefit patients with Duchenne muscular dystrophy (DMD) (IMAGE)

The Institute of Medical Science, The University of Tokyo

Amnion-derived mesenchymal stromal cells (AMSCs) may benefit patients with Duchenne muscular dystrophy (DMD)

Caption

AMSCs polarize macrophages, exert anti-inflammatory effects, facilitate muscle recovery, and improve cardiac function in a mouse model of DMD, according to a new study by researchers from Japan. They have also demonstrated the development of an efficient transplantation strategy for AMSCs for DMD.

Credit

Yuko Nitahara Kasahara, Soya Nakayama, Koichi Kimura, Sho Yamaguchi, Yuko Kakiuchi, Chikako Nito, Masahiro Hayashi, Tomoyuki Nakaishi, Yasuyoshi Ueda and Takashi Okada

Usage Restrictions

This credit must be used when the image used.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.